IP Library › Granted Patent US 6,995,272
Granted Patent B2
US 6,995,272 · App. 10/830,307 · Granted Feb 7, 2006

Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,995,272
App. No.
10/830,307
Granted
Feb 7, 2006
Kind
B2
Abstract

The invention relates to a crystal modification of the compound of the formula I and the processes for the preparation of and use that crystal modifications 1. The invention is used for treating acute immunological episodes, such as sepsis, allergies, graft-versus-host and host-versus-graft-reactions, autoimmune diseases, in particular rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, psoriasis, atopic dermatitis, asthma, urticaria, rhinitis, uveitis, type II diabetes, liver fibrosis, cystic fibrosis, colitis, cancers, such as lung cancer, leukemia, ovarian cancer, sarcomas, Kaposi's sarcoma, meningioma, intestinal cancer, lymphatic cancer, brain tumors, breast cancer, pancreatic cancer, prostate cancer, or skin cancer.

Claims (2)

1. A composition comprising a first crystal modification of a compound of formula (I) and a second crystal modification of a compound of formula (I):

having x-ray diffraction lines wherein the first crystal modification comprises a diffraction line at about 16.1 degrees two-theta and the second crystal modification comprises a diffraction line at about 8.35 degrees two-theta.